Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Improved IOP-lowering prostaglandin analogues from Alcon

Sep. 4, 1997

Alcon reports new agents for controlling IOP

Aug. 26, 1997

CAT's anti-TGF-beta2 antibody approved for phase I/IIa trials

Aug. 26, 1997

FDA approves expansion of Sunrise Technologies' hyperopia study

Aug. 26, 1997

InSite Vision initiates phase II study of ISV-120

Aug. 21, 1997

Generic levobunolol approved in Canada

Aug. 13, 1997

FDA releases Staar's implantable contact lens for phase II trials

Aug. 11, 1997

Boston Life Sciences begins preclinical program for ophthalmic indications of antiangiogenic product

July 18, 1997

New insights into glaucoma and implications for drug therapy

July 15, 1997

Prostaglandins in early development at Allergan for glaucoma

July 4, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 12, 2026.
Europe’s Alzecure, Orionis in $1B+ deals with Lilly, Novartis
BioWorld
Two companies with European ties signed billion-dollar deals with large pharma firms in the last two days to discover and develop molecular glue drugs, as well as...
Ethyreal launches to treat the underlying cause of Graves’, TED
BioWorld
Ethyreal Bio Inc. has come out of stealth mode in order to disclose preclinical data for ETHY-001, its monoclonal antibody targeting thyroid stimulating hormone...
Sanofi phase III CIDP quit dents Dianthus; C1 mismatch?
BioWorld
Investors in Dianthus Therapeutics Inc. apparently chose to ignore subtleties in the difference between efforts with that firm’s claseprubart vs. those by...
Microbiota modulates the antidepressant effects of GLP-1 analogues
BioWorld Science
Liraglutide, a glucagon-like peptide 1 (GLP-1) receptor agonist used in diabetes and obesity, could alleviate depression through a pathway that does not depend on...